Press Releases and Statements

CHPA released the below statement following the passage of A1848 by the New Jersey Assembly today. This legislation seeks to ban the sale of over-the-counter (OTC) weight loss diet pills and dietary supplements marketed for weight loss and muscle building to individuals under 18 years old. While CHPA accepts age restrictions on products explicitly marketed for weight loss, recent amendments to the bill have broadened its scope. The changes now unnecessarily encompass general health supplements containing certain ingredients – including creatine and green tea extract – which are commonly used in many products unrelated to weight loss.

CHPA was pleased to announce today that Dr. Doug Bierer has been honored with its prestigious William Cooley Regulatory & Scientific Affairs Career Achievement Award in recognition of his exceptional service and contributions to the consumer healthcare products industry.

(WASHINGTON, DC) – The Health In Hand Foundation today released the following statement announcing the 2024 U.S. Self-Care Marketing Awards finalists. Winners for each category will be announced at the 9th annual Health In Hand Foundation Gala on November 13 at The Bellevue Hotel in Philadelphia. Specific awards will recognize the strategic innovation and marketing expertise of CHPA member companies across over-the-counter (OTC) medicine, consumer medical device, and dietary supplement categories.

The Consumer Healthcare Products Association (CHPA) released the following statement in response to a recent study published in Environment International regarding the presence of metals in certain tampon products. The study did not assess the risk of metal exposure to tampon users.

The Consumer Healthcare Products Association (CHPA) released the following statement today in response to Aylstock, Witkin, Kreis & Overholtz, PLLC filing a Citizen Petition with the U.S. Food and Drug Administration (FDA), requesting the Agency “recall and suspend sales of benzoyl peroxide (BPO) from the US Market due to the presence of benzene.”

CHPA Senior Vice President of Dietary Supplements Duffy MacKay released the following statement today in response to a recent JAMA Network Open Study investigating the prevalence and characteristics of U.S. adults consuming botanicals potentially linked to liver toxicity:

(WASHINGTON, D.C.) – The Consumer Healthcare Products Association (CHPA) today released the following statement after providing input to U.S. House Energy & Commerce Committee Members, U.S. Representatives Larry Bucshon (IN-08) and Diana DeGette (CO-01), following their request for information from industry stakeholders on how Congress can build upon the 21st Century Cures Act and Cures 2.0 to develop and deliver a new generation of treatments:

Consumer Healthcare Products Association (CHPA) President & CEO Scott Melville released the following statement today in response to U.S. Senator Dick Durbin introducing the Dietary Supplement Listing Act:

The Consumer Healthcare Products Association (CHPA), the leading voice advocating to empower self-care by preserving and expanding access to trusted consumer healthcare products, today released the following statement in recognition of International Self-Care Day, which is recognized annually on July 24:

The Consumer Healthcare Products Association today released the following statement after joining 17 other members of the Health Choices Coalition – a group comprised of healthcare providers, patients, consumers, retailers, manufacturers, pharmacies, insurers, and businesses of all sizes – in sending a letter of support to sponsors of the Oral Health Products Inclusion Act (H.R. 8599). This legislation would increase access to everyday over-the-counter (OTC) oral care products by allowing them to be purchased with Flexible Spending Account (FSA) and Health Savings Account (HSA) funds as “qualified medical expenses.”

(WASHINGTON, D.C.) — Today, the Consumer Healthcare Products Association (CHPA), the national trade association representing the leading manufacturers and marketers of consumer healthcare products, announced the addition of 15 new members, four manufacturers and 11 associate members, from the last quarter. This continues a strong growth trajectory of diverse self-care companies joining the association. CHPA also recognized several of its member companies for reaching significant membership milestone anniversaries this year.

CHPA Senior Vice President of Legal, Government Affairs & Policy David Spangler released the below statement today following the U.S. Supreme Court’s decision to overturn the Chevron standard, a principle of judicial deference used by federal courts for nearly four decades when reviewing a federal agency’s interpretation of a statute it administers: